Rankings
▼
Calendar
CYTK Q1 2023 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena
CYTK
Cytokinetics, Incorporated
$8B
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$5M
+301.8% YoY
Gross Profit
-$75M
-1621.7% margin
Operating Income
-$124M
-2698.3% margin
Net Income
-$131M
-2846.1% margin
EPS (Diluted)
$-1.36
QoQ Revenue Growth
+135.7%
Cash Flow
Operating Cash Flow
-$122M
Free Cash Flow
-$123M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$890M
Total Liabilities
$1.1B
Stockholders' Equity
-$229M
Cash & Equivalents
$102M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5M
$1M
+301.8%
Gross Profit
-$75M
-$45M
-67.0%
Operating Income
-$124M
-$78M
-59.9%
Net Income
-$131M
-$89M
-46.8%
Revenue Segments
Milestone
$3M
54%
Research And Development
$2M
46%
← FY 2023
All Quarters
Q2 2023 →